Ryne Sandberg Shares Details on Prostate Cancer Relapse
Former Chicago Cubs player Ryne Sandberg recently took to social media to share a devastating update regarding his health with his fans. The ex-MLB second baseman first shocked the sporting world in January 2024 when he revealed that he was suffering from metastatic prostate cancer.
HealthDay on MSN46m
Prostate Cancer Incidence, Mortality Rates Mainly Stable, DecreasingIn most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year period ...
Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...
A phase 3 prostate cancer trial of Candel’s oncolytic virus has met its primary endpoint, sending the stock up more than 200% ...
By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said Phase 3 of its prostate cancer candidate CAN-2409 showed an upgrade in disease-free survival in intermediate-to-high-risk patients. “We ...
Montell Jordan is advocating for prostate cancer awareness and emphasizing the importance of early detection, particularly ...
A breakthrough study has identified the genetic risk factors that contribute to increased prostate cancer in African men. The ...
AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target ...
Adoption of active surveillance or watchful waiting has been increasing among patients with intermediate-risk prostate cancer ...
Investigators assessed the oncologic benefit of salvage radiation therapy versus observation for men with biochemical recurrence after radical prostatectomy.
Candel Therapeutics' experimental immunotherapy for prostate cancer significantly improved the time patients lived before their disease returned, helping the company's shares more than double in value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback